Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access September 1, 2004

The synthesis and the structure elucidation of N,O-diacetyl derivative of cyclic 3-hydroxymelatonin

Aleksandra Siwicka, Russel Reiter, Dun Tian, Krystyna Wojtasiewicz, Andrezej Leniewski, Jan Maurin, Dariusz Błachut and Zbigniew Czarnocki
From the journal Open Chemistry

Abstract

Melatonin was subjected to an oxidation to give 3-hydroxymelatonin. All spectroscopic data for this compound were collected. Ab initio calculations for both possible configurations were performed. X-ray data on N,O-diacetyl derivative of 3-hydroxymelatonin allowed the unambigous structure determination.

[1] N. Lysek, E. Rachor and T. Lindel: “Isolation and structure elucidation of deformylflustrabromine from the North Sea bryozoan Flustra foliacea”, Z. Naturforsch, Vol. 57c, (2002), pp. 1056–1061. Search in Google Scholar

[2] Q.S. Yu, X.X. Zhu, H.W. Halloway, N.F. Whittaker, A. Brossi and N.F. Greig: “Anticholinesterase activity of compounds related to geneserine tautomers. N-oxides and 1,2-oxazines”, J. Med. Chem., Vol. 45, (2002), pp. 3684–3691. http://dx.doi.org/10.1021/jm010491d10.1021/jm010491dSearch in Google Scholar

[3] M.S.C. Pedras, F.I. Okanga, I.L. Zaharia and A.Q. Khan: “Phytoalexins from crucifers: synthesis, biosynthesis, and biotransformation”, Phytochemistry, Vol. 53, (2002), pp. 161–176. http://dx.doi.org/10.1016/S0031-9422(99)00494-X10.1016/S0031-9422(99)00494-XSearch in Google Scholar

[4] M. Sabol, P. Kutschy, L. Siegfried, A. Mirossay, M. suchy, H. Hrbkova, M. Dzurilla, R. Maruskova, J. Starkova and E. Paulikova: “Cytotoxic effect of cruciferous phytoalexins against murine L1210 leukemia and B16 melanoma”, Biologia, Vol. 55, (2000), pp. 701–707. Search in Google Scholar

[5] R. Mezencev, J. Mojzis, M. Pilatova and P. Kutschy, “Antiproliferative and cancer chemopreventive activity of phytoalexins: focus on indole phytoalexins from crucifers”, Neoplasma, Vol. 50, (2003), pp. 239–245. Search in Google Scholar

[6] G.A. Potter, L.H. Patterson, E. Wanogho, P.J. Perry, P.C. Butler, T. Ijaz, K.C. Ruparelia, J.H. Lamb, P.B. Farmer, L.A. Stanley and M.D. Burke: “The cancer preventive agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYPIBI”, Brit. J. Cancer, Vol. 86, (2002), pp. 774–778. http://dx.doi.org/10.1038/sj.bjc.660019710.1038/sj.bjc.6600197Search in Google Scholar

[7] M.S.C. Pedras and F.I. Okanga: “Probing the phytopathogenic blackleg fungus with a phytoalexin homolog”, J. Org. Chem., Vol. 63, (1998), pp. 416–417. http://dx.doi.org/10.1021/jo971702i10.1021/jo971702iSearch in Google Scholar

[8] M. Allegra, R.J. Reiter, D.X. Tan, C. Gentile, L. Tesoriere and M.A. Livrea: “The chemistry of melatonin’s interaction with reactive species”, J. Pineal Res., Vol. 34, (2003), pp. 1–10. http://dx.doi.org/10.1034/j.1600-079X.2003.02112.x10.1034/j.1600-079X.2003.02112.xSearch in Google Scholar

[9] R.J. Reiter, D.X. Tan, L.C. Manchester and W. Qi: “Biochemical reactivity of melatonin with reactive oxygen and nitrogen species—A review of the evidence”, Cell Biochem. Biophys., Vol. 34, (2001), pp. 237–256. http://dx.doi.org/10.1385/CBB:34:2:23710.1385/CBB:34:2:237Search in Google Scholar

[10] M. Nakagawa, J. Chiba and T. Hino: “Sensitized photooxygenation of melatonin and related compounds”, Heterocycles, Vol. 9, (1978), pp. 371–382. http://dx.doi.org/10.3987/R-1978-04-038510.3987/R-1978-04-0385Search in Google Scholar

[11] J.A. Horstman, M.Z. Wrona and G. Dryhurst: “Futher insights into the reaction of melatonin with hydroxyl radical”, Bioorg. Chem., Vol. 30, (2002), pp. 371–382. http://dx.doi.org/10.1016/S0045-2068(02)00511-410.1016/S0045-2068(02)00511-4Search in Google Scholar

[12] S. Erkoc, F. Erkoc and N. Keskin: “Theoretical investigation of melatonin and its hydroxy isomers”, J. Mol. Struct (Theochem), Vol. 587, (2002) pp. 73–79. http://dx.doi.org/10.1016/S0166-1280(02)00098-210.1016/S0166-1280(02)00098-2Search in Google Scholar

[13] M.D. Carter and D.F. Weaver: “Ab initio molecular modeling of imadazolium interaction with 5-hydroxy-and 5-methoxyindole: implications for melatonin-based inhibition of alzheimer beta-amyloid fibril formation”, J. Mol. Struct. (Theochem), Vol. 626, (2003), pp. 279–285. http://dx.doi.org/10.1016/S0166-1280(03)00100-310.1016/S0166-1280(03)00100-3Search in Google Scholar

[14] PC Spartan Pro software, version 1.0.5, Aug 16, 2000. Wavefunction, Inc., Irvine, California. Search in Google Scholar

[15] D. Tan, L.C. Manchester, R.J. Reiter, B.F. Plummer, L.J. Hardies, S.T. Weintraub and A.M.M. Shepherd: “A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation”, Biochem. Biophys Res. Commun., Vol. 253, (1998), pp. 614–620. http://dx.doi.org/10.1006/bbrc.1998.982610.1006/bbrc.1998.9826Search in Google Scholar PubMed

[16] G.M. Sheldrick: SHELXL-97 Program for X-ray Structure Refinement, University of Göttingen, Germany, 1997. Search in Google Scholar

Published Online: 2004-9-1
Published in Print: 2004-9-1

© 2004 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow